Cefpodoxime Proxetil + Dicloxacillin Tablets Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP develops Cefpodoxime Proxetil + Dicloxacillin Tablets for mixed bacterial infections involving respiratory tissues, skin structures, and soft tissue regions. The formulation is frequently administered in cellulitis, wound infections, skin abscesses, tonsillitis, and bacterial respiratory complications where dual antibacterial coverage is preferred.

Cefpodoxime Proxetil acts against susceptible gram-negative bacterial pathogens, while Dicloxacillin demonstrates anti-staphylococcal activity against penicillinase-producing gram-positive bacteria. This dual-action combination is commonly utilized in bacterial conditions involving both skin pathogens and respiratory organisms.

Genliva Wellness LLP specializes in oral combination antibiotic manufacturing in Gujarat supplying advanced antibacterial formulations for pharmaceutical distributors, private labeling companies, and export-focused healthcare markets.

Cefpodoxime Proxetil + Dicloxacillin Tablets combine cephalosporin and anti-staphylococcal antibacterial action.

Dual-mechanism oral antibacterial formulation
Frequently prescribed in skin and wound infections
Anti-staphylococcal antibacterial activity profile
Optimized tablet integrity for oral administration
Manufactured using premium pharmaceutical ingredients
Intended for mixed bacterial infection therapies

This formulation is administered in skin, respiratory, and soft tissue bacterial infection treatment.

Treatment of cellulitis and wound infections
Management of skin abscess bacterial conditions
Prescribed in respiratory tract infections
Utilized in soft tissue bacterial therapies
Targets mixed gram-positive and gram-negative pathogens
Frequently selected in outpatient antibacterial care

Cefpodoxime Proxetil + Dicloxacillin Tablets deliver dual antibacterial coverage for mixed infections.

Valuable in skin and soft tissue infection management
Effective against staphylococcal bacterial strains
Broader antibacterial reach in mixed infections
Frequently preferred in wound infection therapies
Combines cephalosporin and penicillin antibacterial action
Maintains strong oral antibacterial performance